Literature DB >> 26324351

Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model.

D Zehn1, E J Wherry.   

Abstract

The development of dysfunctional or exhausted T cells is characteristic of immune responses to chronic viral infections and cancer. Exhausted T cells are defined by reduced effector function, sustained upregulation of multiple inhibitory receptors, an altered transcriptional program and perturbations of normal memory development and homeostasis. This review focuses on (a) illustrating milestone discoveries that led to our present understanding of T cell exhaustion, (b) summarizing recent developments in the field, and (c) identifying new challenges for translational research. Exhausted T cells are now recognized as key therapeutic targets in human infections and cancer. Much of our knowledge of the clinically relevant process of exhaustion derives from studies in the mouse model of Lymphocytic choriomeningitis virus (LCMV) infection. Studies using this model have formed the foundation for our understanding of human T cell memory and exhaustion. We will use this example to discuss recent advances in our understanding of T cell exhaustion and illustrate the value of integrated mouse and human studies and will emphasize the benefits of bi-directional mouse-to-human and human-to-mouse research approaches.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26324351     DOI: 10.1007/978-3-319-15774-0_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  23 in total

1.  cDC1 IL-27p28 Production Predicts Vaccine-Elicited CD8+ T Cell Memory and Protective Immunity.

Authors:  Augustus M Kilgore; Nathan D Pennock; Ross M Kedl
Journal:  J Immunol       Date:  2019-12-23       Impact factor: 5.422

2.  Mouse models of acute and chronic hepacivirus infection.

Authors:  Eva Billerbeck; Raphael Wolfisberg; Ulrik Fahnøe; Jing W Xiao; Corrine Quirk; Joseph M Luna; John M Cullen; Alex S Hartlage; Luis Chiriboga; Kalpana Ghoshal; W Ian Lipkin; Jens Bukh; Troels K H Scheel; Amit Kapoor; Charles M Rice
Journal:  Science       Date:  2017-07-14       Impact factor: 47.728

3.  Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.

Authors:  S Alice Long; Jerill Thorpe; Kevan C Herold; Mario Ehlers; Srinath Sanda; Noha Lim; Peter S Linsley; Gerald T Nepom; Kristina M Harris
Journal:  Cell Immunol       Date:  2017-08-18       Impact factor: 4.868

4.  PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.

Authors:  S Klein; D Ghersi; M P Manns; I Prinz; M Cornberg; A R M Kraft
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

5.  A new vaccination strategy to trigger specific CD4 T-cell response in chronic viral infection.

Authors:  Allan Randrup Thomsen
Journal:  Cell Mol Immunol       Date:  2017-05-08       Impact factor: 11.530

6.  DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer.

Authors:  Meghan Travers; Stephen M Brown; Matthew Dunworth; Cassandra E Holbert; Karla R Wiehagen; Kurtis E Bachman; Jackson R Foley; Meredith L Stone; Stephen B Baylin; Robert A Casero; Cynthia A Zahnow
Journal:  Cancer Res       Date:  2019-05-14       Impact factor: 12.701

7.  IL2Rβ-dependent signals drive terminal exhaustion and suppress memory development during chronic viral infection.

Authors:  Jean-Christophe Beltra; Sara Bourbonnais; Nathalie Bédard; Tania Charpentier; Moana Boulangé; Eva Michaud; Ines Boufaied; Julie Bruneau; Naglaa H Shoukry; Alain Lamarre; Hélène Decaluwe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

Review 8.  Nonhuman primate models of human viral infections.

Authors:  Jacob D Estes; Scott W Wong; Jason M Brenchley
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

Review 9.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.

Authors:  Michael J Topper; Michelle Vaz; Katherine B Chiappinelli; Christina E DeStefano Shields; Noushin Niknafs; Ray-Whay Chiu Yen; Alyssa Wenzel; Jessica Hicks; Matthew Ballew; Meredith Stone; Phuoc T Tran; Cynthia A Zahnow; Matthew D Hellmann; Valsamo Anagnostou; Pamela L Strissel; Reiner Strick; Victor E Velculescu; Stephen B Baylin
Journal:  Cell       Date:  2017-11-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.